Abstract: A method for evaluating an interpretation for a search query is disclosed. The method includes receiving, by one or more processing circuits, a training dataset. The method includes training a first model utilizing the training dataset. The first model is trained to evaluate whether a human interpretation for a search query is correct. The method includes receiving a search query and a human interpretation for the search query. The method includes determining an initial evaluation of whether the human interpretation for the search query is correct utilizing the first model. The method includes generating a second model utilizing the initial evaluation from the first model, temporal features relating to the search query, and cluster features relating to the search query, and determining a final evaluation of whether the human interpretation for the search query is correct utilizing the second model.

Abstract: The present disclosure provides a pillow cover and pillow having a plurality of compartments. The pillow cover includes a top sheet and a bottom sheet that are connected to define a chamber. An envelope is located on the bottom sheet adjacent to the chamber. A releasable fastener is connected to and located between the top sheet and the bottom sheet. The pillow includes a pad located in the envelope and may include an insert located in the chamber.

Abstract: The present disclosure provides a pillow cover (10) and pillow having a plurality of compartments (22). The pillow cover (10) includes a top sheet (12) and a bottom sheet (14) that are connected to define a chamber (16). The plurality of compartments (22) is located on the top sheet (12) opposite the chamber. An envelope (30) is located on the bottom sheet (14) adjacent to the chamber (16). A releasable fastener (40) is connected to and located between the top sheet (12) and the bottom sheet (14). The pillow includes a pad (52) located in the envelope and may include an insert (62) located in the chamber.

Abstract: The present disclosure provides a pillow cover and pillow having a plurality of compartments. The pillow cover includes a top sheet and a bottom sheet that are connected to define a chamber. An envelope is located on the bottom sheet adjacent to the chamber. A releasable fastener is connected to and located between the top sheet and the bottom sheet. The pillow includes a pad located in the envelope and may include an insert located in the chamber.

Abstract: The present disclosure provides a pillow cover (10) and pillow having a plurality of compartments (22). The pillow cover (10) includes a top sheet (12) and a bottom sheet (14) that are connected to define a chamber (16). The plurality of compartments (22) is located on the top sheet (12) opposite the chamber. An envelope (30) is located on the bottom sheet (14) adjacent to the chamber (16). A releasable fastener (40) is connected to and located between the top sheet (12) and the bottom sheet (14). The pillow includes a pad (52) located in the envelope and may include an insert (62) located in the chamber.

Abstract: Sleep mask system comprises a sleep mask having a front and a back, the back having two eye cavities substantially corresponding to the spacing of the user's eyes. A gel pad is removably attachable to the back of the sleep mask, and has eye holes that are aligned with the eye cavities of the sleep mask when attached thereto.

Abstract: An aromatic cover is provided. An aromatic cover includes a flexible enclosure defining an outer surface and an inner surface. A cartridge fastener is attached to the inner surface. The cartridge fastener is configured to releasably retain an aromatic cartridge containing a quantity of aromatic material at a semi-fixed position along the inner surface. An aroma-permeable region of the flexible enclosure is proximate to the semi-fixed position, wherein the aroma-permeable region is configured to allow for a release of the aromatic material from the aromatic cartridge to the outer surface.

Abstract: An aromatic cover is provided. An aromatic cover includes a flexible enclosure defining an outer surface and an inner surface. A cartridge fastener is attached to the inner surface. The cartridge fastener is configured to releasably retain an aromatic cartridge containing a quantity of aromatic material at a semi-fixed position along the inner surface. An aroma-permeable region of the flexible enclosure is proximate to the semi-fixed position, wherein the aroma-permeable region is configured to allow for a release of the aromatic material from the aromatic cartridge to the outer surface.

Abstract: The present invention relates to compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.

Abstract: The present invention relates to a stable pharmaceutical composition comprising an ACE inhibitor or a pharmaceutically acceptable salt or derivative thereof. In particular, the invention relates to a pharmaceutical composition, which comprises an ACE inhibitor, or a pharmaceutically acceptable salt or a derivative thereof, and a C16-C28 glyceride. ACE inhibitors useful in the present invention are susceptible to heat and/or mechanical stress-induced degradation. Preferred ACE inhibitors are ramipril, trandolapril, quinapril and pharmaceutically acceptable salts and derivatives thereof. The composition of the present invention may be for use as a medicament for the treatment or prevention of a cardiovascular disease, a coronary heart disease, a cerebrovascular disease, a peripheral vascular disease, arrhythmia, hypertension, cardiac failure, cardiovascular death, myocardial infraction, stroke or angina.

Abstract: The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises an indole-sulfonamide moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.

Abstract: The present invention relates to compounds having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.

Abstract: The present invention relates to compounds having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.

Abstract: The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises an indole-sulfonamide moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.

Abstract: The present invention relates to compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.

Abstract: The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises a sulfonyl indole moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.

Abstract: Substituted 5-aryl-2,4-thiazolidinediones are potent agonists of PPAR, and are therefore useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR &agr;, &dgr; and/or &ggr; mediated diseases, disorders and conditions.

Abstract: Substituted 5-aryl-2,4-thiazolidinediones are potent agonists of PPAR, and are therefore useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR .alpha., .delta. and/or .gamma. mediated diseases, disorders and conditions.

Abstract: The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.

Abstract: The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.